20
Participants
Start Date
March 31, 2012
Primary Completion Date
August 31, 2012
Study Completion Date
September 30, 2012
PaQ™ insulin infusion device
Basal/bolus insulin therapy administered by CSII for 4 weeks. First two weeks is transition period to identify correct basal rate for the patient, second 2 weeks is treatment period to evaluate efficacy of CSII device.
Medical University of Graz, Graz
Lead Sponsor
International Diabetes Center at Park Nicollet
OTHER
CeQur Corporation
INDUSTRY